63
Participants
Start Date
January 24, 2024
Primary Completion Date
July 9, 2026
Study Completion Date
July 9, 2026
Mavacamten
Specified dose on specified days
Local Institution - 0076, Ciudad Autónoma de Buenos Aires
Local Institution - 0080, Buenos Aires
Local Institution - 0061, Geneva
Local Institution - 0015, Camperdown
Local Institution - 0005, Melbourne
Local Institution - 0085, Chermside
Local Institution - 0058, Lucerne
Local Institution - 0029, Lugano
Local Institution - 0024, Zürich (de)
Local Institution - 0003, Atlanta
Local Institution - 0090, Cleveland
Local Institution - 0017, Houston
Local Institution - 0087, West Hollywood
Local Institution - 0093, Boston
Local Institution - 0086, Pittsburgh
Local Institution - 0035, Murray
Local Institution - 0075, Ciudad Autónoma de Buenos Aires
Local Institution - 0079, Pilar
Local Institution - 0077, Córdoba
Local Institution - 0074, Rosario
Local Institution - 0001, Montreal
Local Institution - 0068, Québec
Local Institution - 0025, Leeds
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY